High-Dose Recombinant Apolipoprotein A-I Milano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E–Deficient Mice
- 26 June 2001
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 103 (25), 3047-3050
- https://doi.org/10.1161/hc2501.092494
Abstract
Background —Repeated doses of recombinant apolipoprotein A-I Milano phospholipid complex (apoA-I m ) reduce atherosclerosis and favorably change plaque composition in rabbits and mice. In this study, we tested whether a single high dose of recombinant apoA-I m could rapidly mobilize tissue cholesterol and reduce plaque lipid and macrophage content in apoE-deficient mice. Methods and Results —High cholesterol–fed, 26-week-old apoE-deficient mice received a single intravenous injection of saline (n=16), 1080 mg/kg dipalmitoylphosphatidylcholine (DPPC; n=14), or 400 mg/kg of recombinant apoA-I m complexed with DPPC (1:2.7 weight ratio; n=18). Blood was sampled before and 1 and 48 hours after injection, and aortic root plaques were evaluated for lipid content and macrophage content after oil-red O and immunostaining, respectively. One hour after injection, the plasma cholesterol efflux–promoting capacity was nearly 2-fold higher in recombinant apoA-I m –treated mice compared with saline and DPPC-treated mice ( P m injection, and it remained significantly elevated at 48 hours ( P m had 40% to 50% lower lipid content ( P P Conclusions —A single high dose of recombinant apoA-I m rapidly mobilizes tissue cholesterol and reduces plaque lipid and macrophage content in apoE-deficient mice. These findings suggest that this strategy could rapidly change plaque composition toward a more stable phenotype.Keywords
This publication has 14 references indexed in Scilit:
- Effect of Up-regulating Individual Steps in the Reverse Cholesterol Transport Pathway on Reverse Cholesterol Transport in Normolipidemic MicePublished by Elsevier BV ,2001
- Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid PlaquesCirculation, 2001
- Stimulation of Fecal Steroid Excretion After Infusion of Recombinant Proapolipoprotein A-ICirculation, 1999
- Effects of Recombinant Apolipoprotein A-I Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient MiceCirculation, 1998
- The Yin and Yang of Oxidation in the Development of the Fatty StreakArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits.Circulation, 1994
- Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Reverse cholesterol transport: Physiology and pharmacologyAtherosclerosis, 1991
- A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.JCI Insight, 1980